yes, you are right with your technicalities their champ. But my point still stands they have $21 mill (not 18) at their disposal. This will get them through the next two quarters comfortably as their revenue builds.
you are clearly only looking at the past and have done a fantastic analysis of that. In The past money has been flowing out, correct, well done, gold star for you.
What you are failing to recognise is that they have literally just brought online Mildura. You fail to revise your analysis to what is currently happening right now. A huge increase in production capacity compared to the past! Lower production costs per unit because we are now doing everything in-house. You are stuck analysing the past my friend. The pertinent point I was making in my original post was don’t expect to see the Mildura development (which IS the pivot to commercialisation and profitability) to produce receipts until September. Which means the next quarterly won’t have revenue skyrocketing either. We will have to wait for Q2 to see the Mildura revenue (albeit around 25% of stage 1a capacity). Might see close to 1T worth of ‘Mildura’ revenue come onto the books.
all will become clearer to you in the coming 6 months. So pay close attention and watch how it all unfolds, you may actually be able To learn a thing or two, just keep an open mind and challenge yourself with trying to understand other points of view other than your own little Ecs echo chamber that you thrive in so much
- Forums
- ASX - By Stock
- CAN
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-13
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.97M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 4.9¢ | $12.01K | 242.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 55373 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 63465 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 55373 | 0.049 |
4 | 195565 | 0.048 |
3 | 85383 | 0.047 |
1 | 42000 | 0.046 |
3 | 64916 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 63465 | 3 |
0.051 | 112102 | 4 |
0.053 | 764181 | 3 |
0.054 | 510000 | 1 |
0.055 | 243261 | 6 |
Last trade - 14.12pm 12/11/2024 (20 minute delay) ? |
Featured News
CAN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online